|
US6266622B1
(en)
*
|
1995-12-13 |
2001-07-24 |
Regents Of The University Of California |
Nuclear receptor ligands and ligand binding domains
|
|
JP2000502086A
(ja)
|
1995-12-13 |
2000-02-22 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
核レセプターのリガンドおよびリガンド結合ドメイン
|
|
US6017958A
(en)
*
|
1996-06-04 |
2000-01-25 |
Octamer, Inc. |
Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
|
|
US6217598B1
(en)
*
|
1997-11-25 |
2001-04-17 |
Linvatec Corporation |
End-cutting shaver blade
|
|
JP2002519340A
(ja)
*
|
1998-06-30 |
2002-07-02 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
甲状腺ホルモン類似体およびそれらの調製方法
|
|
US6723717B1
(en)
|
1999-06-01 |
2004-04-20 |
The University Of Texas Southwestern Medical Center |
Sulfur-containing thyroxane derivatives and their use as hair growth promotors
|
|
MXPA01012494A
(es)
|
1999-06-01 |
2002-07-02 |
Univ Texas Southwestern Med Ct |
Metodo para tratar perdida capilar con el uso de compuestos sulfonil tiromimeticos.
|
|
US6680344B1
(en)
|
1999-06-01 |
2004-01-20 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using diphenylmethane derivatives
|
|
JP2003500432A
(ja)
|
1999-06-01 |
2003-01-07 |
ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター |
ジフェニルエーテル誘導体を用いて脱毛症を処置する方法
|
|
CA2374266A1
(en)
*
|
1999-06-01 |
2000-12-07 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using diphenylmethane derivatives
|
|
US6516294B1
(en)
|
1999-07-01 |
2003-02-04 |
The Regents Of The University Of California |
Nuclear receptor for 1α,25-dihydroxyvitamin D3 useful for selection of vitamin D3 ligands and a method therefor
|
|
DE10024939A1
(de)
*
|
2000-05-19 |
2001-11-29 |
Bayer Ag |
Neue Diphenylmethanderivate für Arzneimittel
|
|
GB0015205D0
(en)
*
|
2000-06-21 |
2000-08-09 |
Karobio Ab |
Bioisosteric thyroid receptor ligands and method
|
|
DE10046029A1
(de)
|
2000-09-18 |
2002-03-28 |
Bayer Ag |
Indazole
|
|
WO2002051805A1
(de)
|
2000-12-27 |
2002-07-04 |
Bayer Aktiengesellschaft |
Indol-derivate
|
|
US6716877B2
(en)
|
2001-01-31 |
2004-04-06 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method to treat chronic heart failure and/or elevated cholesterol levels
|
|
US7504435B2
(en)
*
|
2001-01-31 |
2009-03-17 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method for stimulating weight loss and/or for lowering triglycerides in patients
|
|
US6534676B2
(en)
|
2001-01-31 |
2003-03-18 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
|
|
US6777442B2
(en)
|
2001-03-12 |
2004-08-17 |
Bayer Aktiengesellschaft |
Diphenyl derivatives
|
|
WO2004052302A2
(en)
*
|
2002-12-10 |
2004-06-24 |
The Regents Of The University Of California |
A method for creating specific, high affinity nuclear receptor pharmaceuticals
|
|
US7302347B2
(en)
*
|
2002-12-10 |
2007-11-27 |
The Regents Of The University Of California |
Method for creating specific, high affinity nuclear receptor pharmaceuticals
|
|
EP2428516A1
(en)
*
|
2003-11-19 |
2012-03-14 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing thyromimetics
|
|
WO2005085865A2
(en)
*
|
2004-03-09 |
2005-09-15 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with thyroid hormone receptor beta (thrb)
|
|
US20090232879A1
(en)
|
2005-05-26 |
2009-09-17 |
Metabasis Therapeutics, Inc. |
Thyromimetics for the Treatment of Fatty Liver Diseases
|
|
RU2007148927A
(ru)
*
|
2005-05-26 |
2009-07-10 |
Метабэйзис Терапьютикс, Инк. (Us) |
Новые тиреомиметики, содержащие фосфиновую кислоту
|
|
WO2007002036A1
(en)
*
|
2005-06-24 |
2007-01-04 |
Thomas Lavin |
Tyroid hormone in burn and adipose deposites
|
|
ATE480524T1
(de)
|
2005-07-21 |
2010-09-15 |
Hoffmann La Roche |
Pyridazinonderivate als schilddrüsenhormon- rezeptoragonisten
|
|
GB0606212D0
(en)
*
|
2006-03-28 |
2006-05-10 |
Karobio Ab |
Pharmaceutical compositions
|
|
AU2008219585A1
(en)
*
|
2007-02-27 |
2008-09-04 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome.
|
|
US8076334B2
(en)
|
2007-09-20 |
2011-12-13 |
Hoffmann-La Roche Inc. |
Prodrugs of thyroid hormone analogs
|
|
WO2009089093A1
(en)
*
|
2008-01-04 |
2009-07-16 |
Quatrx Pharmaceuticals Company |
Thyroid hormone receptor agonists
|
|
WO2014178892A1
(en)
|
2013-05-03 |
2014-11-06 |
Scanlan Thomas S |
Use of sobetirome in the treatment of x-linked adrenolenoleukodystrophy
|
|
PE20180021A1
(es)
*
|
2015-02-20 |
2018-01-09 |
Univ Oregon Health & Science |
Derivados de sobetiroma
|
|
WO2017106974A1
(en)
|
2015-12-24 |
2017-06-29 |
Mcmaster University |
Compounds for targeting thyroid hormone receptor alpha isoforms and methods of use thereof
|
|
US11872207B2
(en)
|
2015-12-24 |
2024-01-16 |
Mcmaster University |
Dronedarone and derivatives thereof for treating cancer
|
|
MX382313B
(es)
|
2016-05-18 |
2025-03-13 |
Univ Oregon Health & Science |
Derivados del sobetiroma.
|
|
US11325886B2
(en)
|
2016-08-12 |
2022-05-10 |
Oregon Health & Science University |
Amide compounds, pharmaceutical compositions thereof, and methods of using the same
|
|
WO2018094265A2
(en)
|
2016-11-21 |
2018-05-24 |
Viking Therapeutics, Inc. |
Method of treating glycogen storage disease
|
|
AU2018280118B2
(en)
|
2017-06-05 |
2021-07-15 |
Viking Therapeutics, Inc. |
Compositions for the treatment of fibrosis
|
|
EP3644983B1
(en)
*
|
2017-06-29 |
2023-10-25 |
Yale University |
Compositions and methods of treating or preventing fibrotic lung diseases
|
|
MX2020008498A
(es)
|
2018-02-14 |
2020-09-25 |
Univ Oregon Health & Science |
Derivados de sobetirome.
|
|
EA202091979A1
(ru)
|
2018-03-22 |
2021-06-22 |
Вайкинг Терапьютикс, Инк. |
Кристаллические формы и способы получения кристаллических форм соединения
|
|
EP4775207A2
(en)
|
2018-12-05 |
2026-07-15 |
Viking Therapeutics, Inc. |
Compositions for the treatment of fibrosis
|
|
EP3894383A1
(en)
|
2018-12-12 |
2021-10-20 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
|
CA3130371A1
(en)
|
2019-03-01 |
2020-09-10 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
|
IT201900006923A1
(it)
*
|
2019-05-16 |
2020-11-16 |
International Soc For Drug Development S R L |
Nuovi tiromimetici con uno scaffold bifenilmetano e loro uso
|
|
CN115279359A
(zh)
|
2019-11-29 |
2022-11-01 |
速通医疗公司 |
新型拟甲状腺素药
|
|
CN111116684B
(zh)
|
2019-12-31 |
2020-09-25 |
厦门甘宝利生物医药有限公司 |
一种具有甲状腺激素受体激动剂特性的肝靶向化合物及其药物组合物
|
|
EP4161925A4
(en)
|
2020-06-09 |
2024-09-04 |
Viking Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES
|
|
EP4168384A4
(en)
|
2020-06-17 |
2024-07-10 |
Autobahn Therapeutics, Inc. |
THYROMIMETICS
|
|
WO2021257834A1
(en)
*
|
2020-06-17 |
2021-12-23 |
Autobahn Therapeutics, Inc. |
Thyromimetics
|
|
EP4167986A4
(en)
|
2020-06-17 |
2024-11-20 |
Autobahn Therapeutics, Inc. |
THYROMIMETICS
|
|
AU2022271304A1
(en)
|
2021-05-06 |
2023-11-23 |
Autobahn Therapeutics, Inc. |
Fatty acid amide hydrolase (faah) cleavable prodrugs of thyromimetics and combination with peripherally restricted faah inhibitors
|